ArticleMaxillofacial plastic and reconstructive surgery2025
Clinical outcomes of maxillary sinus augmentation in atrophied posterior maxilla based on residual bone height.
Article in Maxillofacial plastic and reconstructive surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe posterior maxilla is often the site of early tooth loss, frequently requiring sinus augmentation to compensate for vertical bone deficiency. However, the influence of residual bone height (RBH) on clinical outcomes remains unclear. MATERIALS AND
methodsThis retrospective study evaluated 42 patients who underwent maxillary sinus augmentation using either the lateral or transcrestal approach. Patients were divided into two groups: the severely atrophied group (RBH < 3 mm) and the moderately atrophied group (RBH 3-5 mm). Clinical outcomes assessed included marginal bone loss (MBL), graft resorption, complications, and implant survival.
resultsClinical outcomes were comparable regardless of RBH. Even in severely atrophied maxillae with RBH < 3 mm, favorable outcomes were achieved using appropriate surgical techniques.
conclusionRBH should inform surgical planning but should not be considered a strict prognostic indicator.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.